Miss Chui Yan Mah
Research Fellow (B) (with PhD)
SAIGENCI
College of Health
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
Dr Shanice Mah (PhD) is a Postdoctoral Research Fellow at the University of Adelaide, based at the South Australian Health and Medical Research Institute (SAHMRI). She graduated with a Bachelor of Science (Biomedical Science) from the University of Adelaide in 2016 and was awarded a Master of Philosophy (No Honours) International Scholarship to pursue a Doctor of Philosophy in Medicine. Shanice graduated with a PhD in 2021 and is currently a recipient of the Prostate Cancer Foundation of Australia Future Leaders Award for her research focused on developing new therapies for prostate cancer.
| Date | Position | Institution name |
|---|---|---|
| 2023 - ongoing | Cancer Council SA Beat Cancer Project Early Career Research Fellow | University of Adelaide |
| 2022 - 2023 | Prostate Cancer Foundation of Australia Research Fellow | University of Adelaide |
| 2021 - 2022 | Research Officer | University of Adelaide |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2023 | Award | AACR-Prostate Cancer Foundation Scholar-in-Training Award | American Association for Cancer Research (AACR) | United States | $1900 USD |
| 2022 | Nomination | 7News Young Achiever's Award Semi-Finalist | 7News South Australia | Australia | - |
| 2022 | Fellowship | Prostate Cancer Foundation of Australia Future Leaders Award | Prostate Cancer Foundation of Australia | Australia | $100,000 |
| 2021 | Award | 2021 Merdeka Award | Australia Malaysia Business Council SA Inc | Australia | $1000 |
| 2020 | Recognition | Ross Wishart Memorial Award Finalist | Australian Society for Medical Research | Australia | - |
| 2020 | Award | John Barker Bequest Prize in Cancer Research | University of Adelaide | Australia | - |
| 2019 | Award | People's Choice PhD Oral Presentation Award | Australian Society for Medical Research | Australia | - |
| 2017 | Award | Platinum Level of Sponsorship for ABACBS and COMBINE Student Symposium | University of Adelaide | Australia | - |
| 2017 | Achievement | Selection for the 4th Annual EMBL Australia PhD course, 2017 | EMBL Australia | Australia | - |
| 2017 | Scholarship | Freemasons Centre for Male Health and Wellbeing Top-Up Scholarship | Freemasons Foundation Centre for Men's Health | Australia | - |
| 2017 | Scholarship | Master of Philosophy (No Honours) International Scholarship | The University of Adelaide | Australia | - |
| 2016 | Scholarship | Adelaide Summer Research Scholarship 2016 | The University of Adelaide | Australia | - |
| 2015 | Scholarship | Adelaide Summer Research Scholarship 2015 | The University of Adelaide | Australia | - |
| 2015 | Award | Outstanding Academic Achievement Award 2015 & 2016 | The University of Adelaide | Australia | - |
| Language | Competency |
|---|---|
| Chinese (Cantonese) | Can read, write, speak and understand spoken |
| Chinese (Mandarin) | Can read, write, speak and understand spoken |
| English | Can read, write, speak and understand spoken |
| Malay | Can read, write, speak and understand spoken |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2017 - 2021 | The University of Adelaide | Australia | Doctor of Philosophy (Medicine) |
| 2015 - 2016 | The University of Adelaide | Australia | Bachelor of Science (Biomedical Science) |
| Year | Citation |
|---|---|
| 2024 | Mah, C. Y., Nguyen, A. D. T., Niijima, T., Helm, M., Dehairs, J., Ryan, F. J., . . . Butler, L. M. (2024). Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer. British Journal of Cancer, 130(5), 741-754. Scopus16 WoS16 Europe PMC16 |
| 2024 | Shrestha, R. K., Nassar, Z. D., Hanson, A. R., Iggo, R., Townley, S. L., Dehairs, J., . . . Selth, L. A. (2024). ACSM1 and ACSM3 regulate fatty acid metabolism to support prostate cancer growth and constrain ferroptosis. Cancer Research, 84(14), 2313-2332. Scopus24 WoS26 Europe PMC23 |
| 2023 | Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Tables S2-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. |
| 2023 | Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Table S1 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S2 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S1 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Supplementary Figures and Legends 1-8 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Figures S1-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S2 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Figures S1-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Data from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Data from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S1 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S3 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S3 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Data from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Tables S2-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S4 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S4 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Table S1 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. |
| 2023 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Supplementary Figures and Legends 1-8 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. |
| 2023 | Centenera, M. M., Scott, J. S., Machiels, J., Nassar, Z. D., Miller, D. C., Zinonos, I., . . . Butler, L. M. (2023). Data from ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer. |
| 2023 | Centenera, M. M., Scott, J. S., Machiels, J., Nassar, Z. D., Miller, D. C., Zinonos, I., . . . Butler, L. M. (2023). Supplementary Data from ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer. |
| 2023 | Centenera, M. M., Scott, J. S., Machiels, J., Nassar, Z. D., Miller, D. C., Zinonos, I., . . . Butler, L. M. (2023). Supplementary Data from ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer. |
| 2023 | Hinneh, J. A., Gillis, J. L., Mah, C. Y., Irani, S., Shrestha, R. K., Ryan, N. K., . . . Butler, L. M. (2023). Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer. British Journal of Cancer, 129(8), 1350-1361. Scopus11 WoS12 Europe PMC11 |
| 2021 | Schjenken, J. E., Green, E. S., Overduin, T. S., Mah, C. Y., Russell, D. L., & Robertson, S. A. (2021). Endocrine disruptor compounds-a cause of impaired immune tolerance driving inflammatory disorders of pregnancy?. Frontiers in Endocrinology, 12, 607539-1-607539-15. Scopus55 WoS45 Europe PMC39 |
| 2021 | Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S., . . . Swinnen, J. V. (2021). Lipidomic profiling of clinical prostate cancer reveals targetable alterations in membrane lipid composition. Cancer Research, 81(19), 4981-4993. Scopus63 WoS61 Europe PMC59 |
| 2021 | Tangseefa, P., Martin, S. K., Chin, P. Y., Breen, J., Mah, C. Y., Baldock, P. A., . . . Zannettino, A. C. W. (2021). The mTORC1 complex in pre-osteoblasts regulates whole-body energy metabolism independently of osteocalcin. Bone Research, 9(1), 10-1-10-17. Scopus10 WoS12 Europe PMC12 |
| 2021 | Centenera, M. M., Scott, J. S., Machiels, J., Nassar, Z. D., Miller, D. C., Zinonos, I., . . . Butler, L. M. (2021). ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer. Cancer Research, 81(7), 1704-1718. Scopus71 WoS66 Europe PMC70 |
| 2020 | Mah, C. Y., Nassar, Z. D., Swinnen, J. V., & Butler, L. M. (2020). Lipogenic effects of androgen signaling in normal and malignant prostate. Asian Journal of Urology, 7(3), 258-270. Scopus37 WoS35 Europe PMC37 |
| 2020 | Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2020). Fatty acid oxidation is an adaptive survival pathway induced in prostate tumors by heat shock protein 90 inhibition. Molecular cancer research : MCR, 18(10), 1500-1511. Scopus19 WoS18 Europe PMC19 |
| 2020 | Nassar, Z. D., Mah, C. Y., Dehairs, J., Burvenich, I. J., Irani, S., Centenera, M. M., . . . Butler, L. M. (2020). Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis. Elife, 9, 1-34. Scopus151 WoS146 Europe PMC150 |
| 2020 | Asari, P., Roscioli, E., Hurtado, P., Tran, H., Mah, C., & Hodge, S. (2020). LC3-associated phagocytosis (LAP): a potentially influential mediator of efferocytosis-related tumour progression and aggressiveness.. Frontiers in Oncology-Molecular and Cellular Oncology, 10, 1298-1-1298-14. Scopus42 WoS37 Europe PMC36 |
| 2019 | Nassar, Z., Mah, C. Y., Dehairs, J., Burvenich, I. J. G., Irani, S., Centenera, M., . . . Butler, L. (2019). DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis. |
| 2018 | Nassar, Z., Aref, A., Miladinovic, D., Mah, C., Raj, G., Hoy, A., & Butler, L. (2018). Peri-prostatic adipose tissue: the metabolic microenvironment of prostate cancer. BJU International, 121(Suppl. 3), 9-21. Scopus63 WoS58 Europe PMC55 |
| Year | Citation |
|---|---|
| 2023 | Mah, C. Y., Nguyen, A. D., Niijima, T., Helm, M., Dehairs, J., Ryan, F. J., . . . Butler, L. M. (2023). Uncovering a novel role of peroxisomal β-oxidation in advanced, treatment-resistant prostate cancer. In CANCER RESEARCH Vol. 83 (pp. 2 pages). FL, Orlando: AMER ASSOC CANCER RESEARCH. DOI |
| Year | Citation |
|---|---|
| 2023 | Cilento, M. A., Mah, C. Y., Martelotto, L., Sweeney, C. J., & Butler, L. M. (2023). Multiomic analysis workflow for biomarker discovery in human prostate cancer. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY. |
| 2020 | Butler, L. M., Mah, C. Y., Dehairs, J., Vincent, A., Mutuku, S., Spotbeen, X., . . . Swinnen, J. (2020). Phospholipid profiling of clinical prostate tissues reveals targetable alterations in membrane lipid composition accompanying tumorigenesis. Poster session presented at the meeting of CANCER RESEARCH. ELECTR NETWORK: AMER ASSOC CANCER RESEARCH. DOI WoS1 |
| 2020 | Mah, C. Y., Nassar, Z. D., Burvenich, I. J., Irani, S., Centenera, M. M., Moldovan, M., . . . Butler, L. M. (2020). DECR1: The rate limiting enzyme of polyunsaturated fatty acid metabolism and a novel therapeutic target in prostate cancer. Poster session presented at the meeting of CANCER RESEARCH. ELECTR NETWORK: AMER ASSOC CANCER RESEARCH. DOI |
| 2020 | Shrestha, R. K., Townley, S., Hanson, A., Pickering, M., Nassar, Z. D., Mah, C. Y., . . . Selth, L. A. (2020). ACSM1 and ACSM3 regulate fatty acid oxidation in prostate cancer to promote growth and protect against oxidative stress.. Poster session presented at the meeting of CANCER RESEARCH. ELECTR NETWORK: AMER ASSOC CANCER RESEARCH. WoS3 |
| Year | Citation |
|---|---|
| 2022 | Mah, C. Y., Nguyen, A. D. T., Niijima, T., Helm, M., Dehairs, J., Ryan, F., . . . Butler, L. (2022). Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer. DOI |
Grants and Fellowships
CURRENT FELLOWSHIP
- Cancer Council SA Beat Cancer Project Early Career Research Fellowship (part funded by SAiGENCI). MAH CY. 2023-2025. $480,000.
PREVIOUS FELLOWSHIP
- Prostate Cancer Foundation of Australia Priority Impact Research Award - Future Leaders. MAH CY. 2022-2023. $100,000.
CURRENT GRANTS
- The Hospital Research Foundation Innovations in Men's Health Project Grant. MAH CY, Centenera MM, Butler LM, Lynn DJ. 2023-2024. $125,000.
-
Australian Federation of University Women SA Inc. Trust Postdoctoral Grants. MAH CY. 2023. $5,000.
Travel Funding
| Year | Source | Amount |
|---|---|---|
| 2019 | Adelaide Medical School Research Travel Awards, University of Adelaide | $3,000 |
| 2018 | Adelaide Medical School Research Travel Awards, University of Adelaide | $1,000 |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2023 | Co-Supervisor | The impact of high fat diet on plasma ceramides and prostate tumour metastasis | Doctor of Philosophy | Doctorate | Full Time | Miss An Dieu Trang Nguyen |
| 2023 | Co-Supervisor | The impact of high fat diet on plasma ceramides and prostate tumour metastasis | Doctor of Philosophy | Doctorate | Full Time | Miss An Dieu Trang Nguyen |
| Date | Role | Research Topic | Location | Program | Supervision Type | Student Load | Student Name |
|---|---|---|---|---|---|---|---|
| 2023 - ongoing | Co-Supervisor | The Effect of Diet on Prostate Cancer Progression | University of Adelaide | Doctor of Philosophy | Doctorate | Full Time | An Dieu Trang Nguyen |
| 2022 - ongoing | Co-Supervisor | Targeting Fatty Acid Metabolism in Advanced Prostate Cancer | The University of Adelaide | - | Honours | Full Time | An Dieu Trang Nguyen |
| 2020 - ongoing | Co-Supervisor | Targeting Fatty Acid Metabolism in Prostate Cancer | University of Adelaide | Adelaide Medical School | Honours | Full Time | Takuto Nijiima |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2021 - ongoing | Board Member | Australian Society for Medical Research SA State Committee | Australian Society for Medical Research | Australia |
| 2021 - 2021 | Convener | EMBL Australia Postgraduate Symposium | EMBL Australia | Australia |
| 2020 - ongoing | President | Health Sciences Postgraduate Association (HeSPA) | The University of Adelaide | Australia |
| 2018 - 2018 | Member | 2018 ABCABS conference/COMBINE symposium National Program Committee | ABCABS | Australia |
| Date | Role | Membership | Country |
|---|---|---|---|
| 2022 - ongoing | Representative | European Association for Cancer Research | United Kingdom |
| 2020 - ongoing | Member | American Association for Cancer Research (AACR) | United States |
| 2019 - ongoing | Member | Australian Society for Medical Research | Australia |
| 2017 - ongoing | Member | Australian Bioinformatics And Computational Biology Society | Australia |
| 2017 - ongoing | Member | Freemasons Centre for Male Health and Wellbeing | Australia |
Connect With Me
External Profiles
